ARCHIVES

BioProcess International US West 2019

  • Mar 11-14, 2019
  • Santa Clara, CA

ABL will be attending BioProcess International US West from March 11-14, 2019 at the Santa Clara Convention Center in Santa Clara, CA.

Read More

2018 American Society of Hematology Annual Meeting

  • Dec 1-4, 2018
  • San Diego, CA

ABL will be attending the 2018 American Society of Hematology Annual Meeting from December 1-4, 2018 at the San Diego Convention Center in San Diego, CA.

Read More

2018 European Bioanalysis Forum

  • Nov 21-23, 2018
  • Barcelona, Spain

ABL will be attending the 2018 European Bioanalysis Forum from November 21-23, 2018 at the NH Collection Tower in Barcelona, Spain.

Read More

2018 AAPS PharmSci 360 Annual Meeting

  • Nov 4-7, 2018
  • Washington, D.C.

ABL will be attending the AAPS PharmSci 360 Annual Meeting from November 4-7, 2018 at the Walter E. Washington Convention Center in Washington, D.C.

Read More

2018 Immunogenicity & Bioassay Summit

  • Oct 23-26, 2018
  • Washington, D.C.

ABL will be attending the 2018 Immunogenicity & Bioassay Summit from October 23-26, 2018 at the Westin Alexandria in Alexandria, Virginia.

Read More

2018 ECTRIMS Congress

  • Oct 10-12, 2018
  • Berlin, Germany

ABL will be attending the 2018 ECTRIMS Congress October 10-12, 2018 at the City Cube Berlin in Berlin, Germany.

Read More

2018 Cell & Gene Meeting on the Mesa

  • Oct 3-5, 2018
  • La Jolla, CA

ABL will be attending the 2018 Cell & Gene Meeting on the Mesa from October 3-5, 2018 at the Sanford Consortium for Regenerative Medicine in La Jolla, California.

Read More

Bio+Tech 18

  • Sep 20, 2018
  • Baltimore, MD

ABL will be attending Bio+Tech 18 on September 20, 2018 at the Baltimore Hilton in Baltimore, MD.

Read More

2018 BIO International Convention

  • Jun 4-7, 2018
  • Boston, MA

ABL will be attending the 2018 BIO International Convention from June 4-7, 2018 at the Boston Convention & Exhibition Center in Boston, MA.

Read More

ASGCT 2018 Annual Meeting

  • May 16-19, 2018
  • Chicago, IL

ABL will be attending the ASGCT 2018 Annual Meeting from May 16-19, 2018 at the Hilton Chicago in Chicago, IL.

Read More

PEGS Boston: The Essential Protein Engineering Summit

  • Apr 30, 2018-May 4, 2018
  • Boston, MA

ABL will be attending PEGS Boston: The Essential Protein Engineering Summit from April 30-May 4, 2018 at the Seaport World Trade Center in Boston, MA.

Read More

2018 World Vaccine Congress

  • Apr 2-5, 2018
  • Washington, D.C.

ABL will be attending the World Vaccine Congress from April 2-5, 2018 at the Renaissance Washington DC Downtown Hotel in Washington, D.C.

Read More

BioProcess International West

  • Mar 19-22, 2018
  • San Francisco, CA

ABL will be attending BioProcess International West from March 19-22, 2018 at the Hilton San Francisco Union Square in San Francisco, CA.

Read More

Advances in Alzheimer’s and Parkinson’s Therapies Focus Meeting

  • Mar 15-18, 2018
  • Torino, Italty

ABL will be attending this AAT-AD/PDTM Focus Meeting 2018 from March 15-18, 2018 in Torino, Italy.

Read More

ISBiotech 8th Spring Meeting

  • Mar 5-7, 2018
  • Norfolk, VA

ABL will be attending the ISBiotech 8th Spring Meeting from March 5-7, 2018 at the Hilton Norfolk in Norfolk, VA.

Read More

13th Congress of European Crohn’s and Colitis Organisation

  • Feb 14-17, 2018
  • Vienna, Austria

ABL will be attending the 13th Congress of ECCO from February 14-17, 2018 at Reed Messe Wien in Vienna, Austria.

Read More

ImmunoTX Summit

  • Jan 30-31, 2018
  • San Diego, CA

ABL will be attending the ImmunoTX Summit from January 30-31, 2018 at the Coronado Island Marriott Resort in San Diego, CA.

Read More

Phacilitate – Cell & Gene Therapy World

  • Jan 22-25, 2018
  • Miami, FL

ABL will be attending Phacilitate’s Cell & Gene Therapy World from January 22-25, 2018 at the Hyatt Regency Miami in Miami, Florida.

Read More

2017 Oncolytic Virotherapy Summit

  • Dec 5-7, 2017
  • Miami, FL

ABL will be attending 2017 2017 Oncolytic Virotherapy Summit from December 5-7, 2017 at Shula’s Hotel & Golf Club in Miami, Florida.

Read More

European Bioanalysis Forum

  • Nov 15-17, 2017
  • Barcelona, Spain

ABL Lyon will be attending the European Bioanalysis Forum from November 15 – November 17, 2017 at the Hotel NH Collection Barcelona in Barcelona, Spain.

Read More

European Antibody Congress 2017

  • Oct 31, 2017-Nov 2, 2017
  • Basel, Switzerland

ABL Lyon will be attending the European Antibody Congress 2017 from October 31 to November 2, 2017 at the Congress Center Basel in Basel, Switzerland.

Read More

ESGCT XXV Anniversary Congress

  • Oct 17-20, 2017
  • Berlin, Germany

ABL Europe will be attending the ESGCT XXV Anniversary Congress from October 17-20, 2017 at the bcc Berlin in Berlin, Germany.

Read More

2017 Contract Pharma

  • Sep 14-15, 2017
  • New Brunswick, NJ

ABL will be attending the The 16th Annual Contracting & Outsourcing Conference & Tabletop Exhibition from September 14-15, 2017 at the Hyatt Regency in New Brunswick, NJ.

Read More

2017 Immuno-Oncology Summit

  • Aug 28, 2017-Sep 1, 2017
  • Boston, MA

ABL will be attending the 2017 Immuno-Oncology Summit from August 28 – September 1, 2017 at the Sheraton Boston Hotel in Boston, MA.

Read More

2017 BIO International Convention

  • Jun 19-22, 2017
  • San Diego, CA

ABL will be attending the 2017 BIO International Convention from June 19-22, 2017 at the San Diego Convention Center in San Diego, CA.

Read More

ASGCT 2017 Annual Meeting

  • May 10-13, 2017
  • Washington, D.C.

ABL will be attending the ASGCT 20th Annual Meeting from May 10-13, 2017 at the Marriott Wardman Park Hotel in Washington, D.C.

Read More

15th CIMT Annual Symposium

  • May 10-11, 2017
  • Mainz, Germany

ABL will be attending the 15th CIMT Annual Symposium from May 10-11, 2017 at Frankfurter Hof in Mainz, Germany.

Read More

Bio+Tech 17 Conference

  • Apr 27-28, 2017
  • North Bethesda, MD

ABL will be attending Bio+Tech 17 from April 27-28, 2017 at the Bethesda North Marriott Hotel & Conference Center in North Bethesda, MD.

Read More

Pall ForteBio User Meeting

  • Apr 25, 2017
  • Bethesda, MD

ABL will be presenting at the Pall ForteBio User Meeting on April 25, 2017 at the Bethesda North Marriott Hotel & Conference Center in Bethesda, MD.

Read More

17th Annual World Vaccine Congress

  • Apr 10-12, 2017
  • Washington, D.C.

ABL will be attending the 17th Annual World Vaccine Congress from April 10-12, 2017 at the Grand Hyatt in Washington, D.C.

Read More

First International Symposium on Immune Responses in Cancer and Infection

  • Feb 13-15, 2017
  • Lyon, France

ABL will be attending the First International Symposium on Immune Responses in Cancer and Infection (IRCI) from February 13-15, 2017 at the Ecole Normale Supérieure de Lyon in Lyon, France.

Read More

2017 ImmunoTX Summit

  • Feb 6-7, 2017
  • San Diego, CA

ABL will be attending GTCbio’s ImmunoTX Summit from February 6-7, 2017 at the Hard Rock Hotel in San Diego, California.

Read More

SITC 2016

  • Nov 9-13, 2016
  • National Harbor, MD

ABL’s Immunobiology Services team will be attending the 2016 SITC conference from November 9-13, 2016 at the Gaylord National Hotel & Convention Center in National Harbor, Maryland.

Read More

Contract Pharma 15th Annual Conference and Tabletop Exhibition

  • Sep 22-23, 2016
  • New Brunswick, NJ

ABL will be exhibiting at the 15th Annual Contract Pharma – Contracting & Outsourcing Conference & Tabletop Exhibition on Thursday, September 22, 2016 at the Hyatt Regency in New Brunswick, NJ.

Read More

Join ABL at BIO2016 in San Francisco June 6-9

  • Jun 6-9, 2016
  • Moscone Center, San Francisco, CA

Stop by and see ABL at booth # 2605 when we return to the Bay Area for the 2016 BIO International Convention.

Read More

ABL at 2016 ASGCT Annual Meeting in DC May 4-6

  • May 4-6, 2016
  • Marriot Wardman Park in Washington, DC

Stop by Booth 418 during the exhibit hall hours to discuss your project goals and how ABL can support your program through our manufacturing and contract research service offerings.

Read More

Join ABL at PEGS in Boston

  • Apr 25-29, 2016
  • Seaport World Trade Center Boston, MA

Boston, MA—March 11, 2016 – ABL will be at the 12th Annual PEGS Boston conference at the Seaport World Trade Center from April 25-29. PEGS is a protein engineering summit with 8 streams for presentations and discussions

Read More

ABL at World Vaccine Congress 2016

  • Mar 29-31, 2016
  • the Grand Hyatt in Washington, DC

Washington, D.C.—March 11, 2016 – ABL is attending World Vaccine Congress 2016 at the Grand Hyatt in Washington, DC from March 29 – 31st.

Read More

ABL Will Have Daily Sessions at Our Booth at the GTC Biomarker Summit 2016

  • Mar 21-23, 2016
  • San Diego, CA

San Diego, CA—March 11, 2016 – ABL will be exhibiting at the GTC Biomarker Summit 2016 in San Diego March 21-23. We welcome you to join us at one of our daily sessions to meet ABL’s new Director of Immunobiology, Dr. Andrew Macintyre, and to discuss both our preclinical and clinical service offerings.

Read More

Find ABL at GTCbio’s Novel Immunotherapeutics Summit 2016

  • Jan 25-26, 2016
  • San Diego, CA

San Diego, CA – January 7, 2016 – Find ABL at GTCbio’s Novel Immunotherapeutics Summit 2016 in San Diego, CA Jan 25-26. ABL is attending Global Technology Community’s (GTCbio’s) Novel Immunotherapeutics Summit 2016 at the Paradise Point Resort & Spa.

Read More

Meet ABL at Phacilitate Cell & Gene Therapy World

  • Jan 25-27, 2016
  • the Grand Hyatt in Washington, DC

Washington, D.C. – January 7, 2016 – ABL will be attending the Phacilitate Cell & Gene Therapy World conference at the Grand Hyatt in Washington, DC from January 25-27. Stop by our booth (#210) to talk about ABL’s biomanufacturing andresearch services. We are based in Rockville, Maryland and would be pleased to host any out of town visitors who would like to tour our facility on their trip.

Read More

ABL Attending BARDA Industry Day in DC

  • Oct 14-15, 2015
  • Ronald Reagan Building & International Trade Center in Washington, DC

Rockville, MD – October 13, 2015 – ABL will have representatives at BARDA Industry Day at the Ronald Reagan Building & International Trade Center in Washington, DC to learn more about BARDA’s key initiatives. We are available to talk to our partners about continuing to provide immunoassay and biomanufacturing support toward developing medical countermeasures.

Read More

Join ABL at BIO in Philadelphia

  • Jun 15-18, 2015
  • Philadelphia, PA

Philadelphia, PA – June 11, 2015 – Come to ABL’s booth (#3632) at the BIO International Convention in Philadelphia, PA June 15-18. ABL representatives will be available to discuss ABL’s preclinical and clinical immunological testing, cGMP biomanufacturing services, and potential partnerships. ABL now has sites in the US and France in order to better serve our clients’ global programs.

Read More

ABL Attending Annual Meeting of the American Society of Gene and Cell Therapy

  • May 13-16, 2015
  • New Orleans, LA

New Orleans, LA – May 13, 2015 – ABL will attend the 18th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT). The meeting will be held in New Orleans on May 13-16. This meeting will bring together the world’s top researchers and clinicians in the field for education, presentations, networking, and social events.

Read More

ABL Sponsoring Atlantic Vaccines and Immunotherapeutics Summit

  • May 7-8, 2015
  • Bethesda, Maryland

Bethesda, MD – May 7, 2015 – ABL is a sponsor of the Atlantic Vaccines and Immunotherapeutics Summit being held in Bethesda, Maryland on May 7-8.

Read More

ABL to Attend PEGS Boston

  • May 4-8, 2015
  • Seaport World Trade Center in Boston, MA

Boston, MA – May 4, 2015 – ABL staff will attend the 11th Annual PEGS Boston conference being held at the Seaport World Trade Center in Boston, MA on May 4-8. The PEGS conference focuses on antibody and protein science research and the biologics industry.

Read More

ABL Promoting US and French Sites at BIO-Europe Spring

  • Mar 9-11, 2015
  • Porte de Versailles Paris, France

Paris, France – February 25, 2015 – ABL will be attending EMD’s BIO-Europe Spring in Paris, France. The conference will take place in the Paris Expo – Porte de Versailles, Hall 5 on March 9-11. ABL is excited to discuss clinical and preclinical immunoassay services in both the US and France, as well as other service offerings, including GMP manufacturing of vaccines and proteins.

Read More

Join ABL at Phacilitate Jan. 26-28 – Director of Immunobiology to Discuss the Future of Cancer Immunotherapies

  • Jan 26-28, 2015
  • the Grand Hyatt in Washington, D.C.

Washington, D.C. – January 20, 2015 – ABL is attending the Phacilitate conference to speak with industry leaders on immunological research and cGMP biologics manufacturing opportunities across all three simultaneous forums. The conference, hosted at the Grand Hyatt in Washington, D.C. January 26-28, 2015, has over 150 speakers in their Cell & Gene Therapy Forum, Immunotherapy Forum, and Stem Cells as Discovery Research Tools Forum.

Read More

ABL Attends ImVacs Immunotherapies and Vaccine Summit

  • Aug 11-13, 2014
  • Boston

ABL attended the 9th Annual Immunotherapeutics and Vaccine Summit (ImVacs) in Boston from August 11-13.

Read More

Meet With ABL Executives and Staff at the BIO International Convention

  • Jun 23-26, 2014
  • San Diego, CA

ABL senior executives and staff will attend the 2014 BIO International Convention in San Diego from June 23 – 26. BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations in the US and across the globe who are involved in the research and development of innovative biotechnology products.

Read More

ABL to Attend Life Science Innovation Northwest 2014

  • Jun 19-20, 2014
  • Seattle, WA

Representatives from ABL will attend the Life Science Innovation Northwest 2014 conference in Seattle, WA on June 19 – 20. This meeting focuses on trends and breakthroughs by life science leaders, innovators, and start-ups.

Read More

ABL to Attend PEGS Proteing Engineering Summit in Boston

  • May 5-9, 2014
  • Boston, MA

ABL staff will attend the 2014 PEGS Protein Engineering Summit in Boston from May 5-9. PEGS brings together subject matter experts across a wide range of biologic production and bioprocess areas.

Read More

ABL Director of Immunobiology to Attend AACR Conference

  • Apr 5-9, 2014
  • San Diego, CA

ABL’s Director of Immunobiology, Dr. Anthony Cristillo, will attend the American Association of Cancer Research (AACR) Annual Meeting in San Diego, CA on April 5-9. In recent years Dr. Cristillo has spearheaded the development and launch of GCLP-compliant clinical trial sample testing services at ABL.

Read More

ABL to Attend MassBio Annual Meeting

  • Apr 3, 2014
  • Cambridge, MA

ABL staff will attend the annual meeting of the Massachusetts Biotechnology Council (MassBio), an association of more than 600 biotechnology companies, universities, academic institutions and others dedicated to advancing cutting edge research.

Read More

ABL Director of Immunobiology to Present at World Vaccine Congress

  • Mar 24-26, 2014
  • Washington, D.C.

ABL’s Director of Immunobiology, Dr. Anthony Cristillo, will present a poster at the World Vaccine Congress being held in Washington, DC on March 24- 26. In recent years Dr. Cristillo has spearheaded the development and launch of GCLP-compliant clinical trial sample testing services at ABL.

Read More

ABL to Attend IBC Biopharmaceutical Development and Production Week

  • Mar 24-27, 2014
  • San Diego, CA

ABL representatives will attend IBC Biopharmaceutical Development and Production Week (BDP) in San Diego, CA on March 24-27. BDP Week is an opportunity for those involved in bioprocess development and manufacturing to come together and discuss new developments and best practices in the production of large molecule therapeutics, including mAbs, vaccines, recombinant proteins, bispecifics, enzymes, biosimilars and cell/gene therapy products.

Read More

Meet with ABL at the ASM Biodefense and Emerging Diseases Meeting, January 27-29

  • Jan 27-29, 2014
  • Washington, D.C.

The ASM Biodefense and Emerging Diseases Research Meeting will be held in Washington, DC from January 27-29. Representatives from ABL will be in attendance, including our Scientific Director, Dr. Gerald Kovacs.

Read More

9th Annual Non-Dilutive Funding Conference to Feature NHLBI

  • Jan 15, 2014
  • San Francisco, CA

The 9th Annual Non-Dilutive Funding Summit will be held in San Francisco on January 15. This year’s meeting will feature a keynote presentation and round table discussion from the National Heart, Lung, and Blood Institute (NHLBI). Dr. Jodi Black, Deputy Director of the Division of Extramural Research Activities for NHLBI and Larry Hahan, Director of the Office of Translational Alliances & Coordination for NHLBI will be presenting and participating.

Read More

Meet with ABL Representatives at Biotech Showcase, January 13-15

  • Jan 13-15, 2014
  • San Francisco, CA

Representatives from ABL will attend the Biotech Showcase in San Francisco January 13 – 15. The Biotech Showcase is a meeting that provides biotech companies and innovators with the opportunity to discuss partnering opportunities.

Read More

ABL will Attend BARDA Industry Day Nov. 12-14 in Washington, DC

  • Nov 12-14, 2013
  • Ronald Reagan Building & International Trade Center, Washington, D.C.

ABL will attend Biomedical Advanced Research and Development Authority (BARDA)’s Industry Day at the Ronald Reagan Building & International Trade Center on November 12-14. ABL is interested in partnering opportunities with other companies or groups in order to successfully answer BARDA initiatives.

Read More

Connect with ABL at the Immunogenicity Summit Nov. 11-13 in DC

  • Nov 11-13, 2013
  • Hyatt Regency on Capitol Hill, Washington, D.C.

As leaders in immunological evaluations, ABL will attend the Immunogenicity Summit 2013 at the Hyatt Regency on Capitol Hill in Washington, D.C. on November 11-13. Come visit Booth #15.

Read More

Transcriptomic Research Performed at ABL Presented at AIDS Research Conference

  • Nov 4, 2013
  • Atlanta, GA

ABL Senior Staff Scientist Dr. Hye K. Chung is author on a poster being presented at the 31st Annual Symposium on Nonhuman Primate Models for AIDS in Atlanta, GA. The poster title is “High monocyte turnover is associated with high SIV DNA, but not RNA, levels in the brain of SIV-infected rhesus macaque.”

Read More

ABL will be at IIR’s 9th Annual Bioassays and Bioanalytical Method Development Oct. 7-9

  • Oct 7, 2013
  • Claremont Club & Spa, Berkeley, California

ABL is attending IIR’s 9th Annual Bioassays and Bioanalytical Method Development in Berkeley, California at the Claremont Club & Spa. The meeting is designed to bring leaders in research and development together to discuss the challenges and opportunities available to them in the Bioanalytical methods arena.

Read More

Talk with ABL at Contract Pharma’s Contracting and Outsourcing Conference Sept. 19-20

  • Sep 19-20, 2013
  • Hyatt Regency, New Brunswick, NJ

ABL will be exhibiting at the 12th Annual Contracting & Outsourcing Conference & Tabletop Exhibition, devoted to outsourcing in the pharma and biopharma industries. The conference will take place September 19-20, 2013 at the Hyatt Regency in New Brunswick, NJ.

Read More

ABL Attended ImVacs Conference in Boston, August 13-15

  • Aug 13-15, 2013
  • Hilton Boston Back Bay Hotel, Boston, MA

The 8th Annual Immunotherapeutics and Vaccine Summit (ImVacs) is taking place at the Hilton Boston Back Bay hotel in Boston on August 13-15. ABL representatives will be on site to discuss how ABL applies our research and manufacturing capabilities to the development of immunotherapeutics and vaccines.

Read More

Learn about ABL’s Clinical Immunomonitoring at the 49th Annual DIA Conference in Boston, MA

  • Jun 23-27, 2013
  • Boston Convention and Exhibition Center, Boston, MA

The 49th Annual DIA Conference for Advancing Therapeutic Innovation and Regulatory Science takes place June 23-27 at the Boston Convention and Exhibition Center. ABL staff will be available to discuss ABL’s long history of preclinical immunomonitoring experience and the expansion to the development of new clinical immunomonitoring capabilities.

Read More

ABL Attending 11th Annual Emerging Infectious Diseases and Biodefense Conference

  • Jun 17-19, 2013
  • Almas Temple Club, Washington, D.C.

The 11th Annual Emerging Infectious Diseases and Biodefense Conference is taking place at the Almas Temple Club in Washington, DC on June 17-19. ABL will be exhibiting to discuss service offerings to help clients develop medical countermeasures and diagnostics against emerging infectious diseases and for CBRN concerns.

Read More

ABL Attended BIO International Convention

  • Apr 22-25, 2013
  • Chicago, IL

ABL was at the BIO International Convention in Chicago, IL from April 22 to April 25, 2013. ABL’s Director of Commercial Services, Dr. James Richardson, made a presentation on overcoming road blocks in the development of novel vaccines for infectious diseases.

Read More

ABL Presented at World Vaccine Congress

  • Apr 17, 2013
  • Gaylord National Resort and Convention Center, National Harbor, MD

ABL’s Associate Director of Product Development, Dr. Anthony Cristillo, presented at the World Vaccine Congress on April 17, 2013 titled “Increased Antibody Breadth Following Immunization with an HIV-1 Envelope-Based DNA Prime/Protein Boost Vaccine.”

Read More

ABL Attended Society of Toxicology Meeting

  • Mar 10-14, 2013
  • San Antonio, TX

ABL scientists and staff attended and exhibited at this year’s Society of Toxicology meeting in San Antonio, Texas from March 10 to March 14. The Society of Toxicology (SOT) is a professional organization of scientists from academic institutions, government, and industry representing the great variety of scientists who practice toxicology in the US and abroad.

Read More

ABL Exhibited at Biopharmaceutical Development & Production Week

  • Feb 25, 2013-Mar 1, 2013
  • Huntington Beach, CA

ABL attended the IBC Biopharmaceutical Development & Production Conference in Huntington Beach, CA from February 25 to March 1. The meeting focused on Development, Production and Regulatory Challenges of antibodies and novel molecules.

Read More

ABL Attended Keystone Symposia on HIV Vaccines

  • Feb 10-15, 2013
  • Keystone, CO

ABL scientists and staff attended the Keystone Symposia on HIV Vaccines in Keystone, Colorado from February 10 to February 15. The HIV Vaccines meeting is part of the Keystone Symposia Global Health Series and is supported by the Bill & Melinda Gates Foundation.

Read More

ABL Exhibits at Phacilitate Vaccine Forum

  • Jan 28-30, 2013
  • Washington, D.C.

ABL participated at the Phacilitate 2013 Vaccine Forum in Washington, DC from January 28 to January 30.

Read More

ABL Attends Biotech Showcase

  • Jan 7-9, 2013
  • San Francisco, CA

ABL attended the Biotech Showcase in San Francisco from January 7 to January 9.

Read More

ABL Attends Immunological Mechanisms of Vaccination Symposium

  • Dec 13-18, 2012
  • Fairmont Chateau Laurier, Ottawa, Ontario, Canada

ABL scientists and staff attended the Immunological Mechanisms of Vaccination Symposium at the Fairmont Chateau Laurier in Ottowa, Ontario, Canada, from December 13 to December 18. The symposium is part of the Keystone Symposia Global Health Series which is supported by the Bill & Melinda Gates Foundation.

Read More

ABL at BARDA Industry Day

  • Dec 10-12, 2012
  • Washington Plaza Hotel, Washington, DC.

ABL will be attending BARDA Industry Day on December 10-12, 2012. The conference will be held at the Washington Plaza Hotel in Washington, DC.

Read More

Dr. Chung Presents Her Work on Viral Latency at 30th Annual Symposium on NHP Models for AIDS

  • Oct 24-27, 2012
  • San Antonio, TX

The 30th Annual Symposium for NHP Models for AIDS was held in San Antonio, TX from October 24 to October 27, 2012.

Read More

Dr. Anthony Cristillo Presented at the International Conference on Clinical and Cellular Immunology Conference

  • Oct 22-24, 2012
  • Chicago, IL

Dr. Anthony Cristillo presented his research on, “Increased Antibody Breadth in Lupus Rabbits Immunized with an Envelope-Based HIV-1 DNA Prime/Protein Boost Vaccine” in Track 5:HIV at the Clinical and Cellular Immunology Conference.

Read More

NHLBI Mid-Atlantic Innovation Conference

  • Oct 15, 2012
  • Rockville, MD

ABL attended the National Heart Lung and Blood Institute Mid-Atlantic Conference representing our SMARTT Biologics Production contract and exploring new opportunities.

Read More

Meet ABL Investigators at the 14th Annual International Meeting of the Institute of Human Virology

  • Oct 14-17, 2012
  • College Park, MD

ABL scientists will be meeting with other leading virologists to discuss the newest advances in HIV biology and vaccine development.

Read More

ABL Presented at AIDS Vaccine 2012 meeting in Boston Sept 9 – 12

  • Sep 9-12, 2012
  • Boston, MA

In a poster session, Dr. Veena Menon will be presenting results of ongoing ABL studies conducted in collaboration with Duke and Flinders Medical Centre.

Read More

ABL Had a Successful Show at BIO2012 in Boston June 18-21

  • Jun 18-21, 2012
  • Boston, MA

ABL attended the 2012 BIO International Convention from June 18 to June 21.

Read More

ABL at BioDefense Conference June 5-8, Washington, DC

  • Jun 5-8, 2012
  • Washington, D.C.

ABL will be at the 10th Annual BioDefense Vaccines & Therapeutics Summit.

Read More

Mucosal and Systemic Immune Responses: Design and Evaluation of Novel Enveloped Vaccines

  • Jun 4, 2012
  • Mass Bio, Cambridge, MA

Anthony Cristillo, Ph.D., Associate Director of Product Development of ABL, Inc. presented recent work at MassBio, 300 Technology Square, 8th Floor, Cambridge, MA on Monday, June 4th.

Read More

ABL at AAPS in San Diego, CA

  • May 21-23, 2012
  • Sheraton San Diego Hotel and Marina, San Diego, CA

The 2012 American Association of Pharmaceutical Scientists, AAPS, National Biotechnology Conference presentations and discussions should be of interest to scientists who are devoted to advancing health through innovations in biotherapeutics.

Read More

ABL’s Science and Services at ASGCT in Phila, PA May 16-18

  • May 16-18, 2012
  • Philadelphia, PA

Visit ABL at the American Society of Gene and Cell Therapy (ASGCT) 15th Annual Meeting and Training Course.

Read More

ABL in 16th Annual Merck Technology Symposium

  • May 8-9, 2012
  • Ocean Place Resort and Spa, Long Branch, NJ

Merck’s 16th Annual Technology Symposium Will Bring Together Over 700 R&D Scientists From Across Merck.

Read More

Visit ABL at World Vaccine Congress

  • Apr 10-13, 2012
  • Gaylord National Hotel and Convention Center, Washington, D.C.

ABL is exhibiting at the World Vaccine Congress 2012.

Read More

ABL Exhibiting at the IBC Biopharmaceutical Development and Production Week

  • Feb 27, 2012-Mar 4, 2012
  • San Diego, CA

ABL will be exhibiting at the IBC Biopharmaceutical Development and Production Week in San Diego from Feb. 27 to Mar. 4, 2012. The event combines multiple tracts covering the latest perspectives on antibodies, recombinant proteins, biosimilars, and outsourcing topics in the biologics industry.

Read More

ABL Display at Phacilitate in Washington, D.C.

  • Jan 30, 2012-Feb 1, 2012
  • Washington, D.C.

ABL recently attended Phacilitate’s 8th Annual Cell & Gene Therapy Forum.

Read More

ABL Exhibited at the BioProcess International Conference and Exhibition

  • Nov 1-3, 2011
  • Long Beach, CA

ABL recently attended and exhibited at the BioProcess International Conference and Exhibition.

Read More

ABL’s Senior Scientific Staff Presented HIV Vaccine Strategies

  • Oct 30, 2011-Nov 2, 2011
  • Baltimore Marriott Waterfront Hotel, Baltimore, MD

ABL’s senior scientific staff presented HIV vaccine strategies at the 13th Annual International Meeting of the Institute of Human Virology.

Read More

Dr. Anthony Cristillo Presented at the 13th Annual IHV International Meeting

  • Oct 30, 2011-Nov 2, 2011
  • Marriott Waterfront Hotel, Baltimore, MD

Evaluation of Novel HIV Envelopes in Rabbits Immunized with a DNA Prime/Protein Boost Vaccine Regimen

Read More

ABL Represented at 6th IAS Conference on HIV Pathogenesis, Treatment, and Prevention

  • Jul 17-20, 2011
  • Rome, Italy

The International AIDS Society (IAS) 2011 conference was held in Rome, Italy from July 17-20, where Dr. Frank Lemiale of VIRxSYS presented work conducted with ABL in which Dr. Tony Cristillo is a co-author.

Read More

Advanced BioScience Laboratories Celebrates Opening New Research and Manufacturing Facility with Biotech and Community Partners

  • Jun 3, 2011
  • Rockville, MD

Rockville, MD (June 6, 2011) – Advanced BioScience Laboratories, Inc., (ABL) held an Open House June 3rd to celebrate the strategic expansion of its vaccine and biotherapeutic product development capabilities at the new headquarters located at 9800 Medical Center Drive, Building D in the Shady Grove Life Sciences Center in Rockville, Maryland.

Read More

ABL Presented at EB2011

  • Apr 9-13, 2011
  • Washington, D.C.

ABL presented about acute rapamycin administration controls ubiquitination and enhanced Akt activation in pressure-induced cardiac hypertrophy in rats.

Read More

Dr. Grazia Ferrari Presented at the AIDS Vaccine 2010

  • Sep 28, 2010-Oct 1, 2010
  • Atlanta, GA

Dr. Grazia Ferrari presented about prime-boost vaccination via parental and mucosal routes induces systemic and mucosal immunity and control of plasma viremia following heterologous SHIV challenge.

Read More